Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-08

Clinical Trial Update: Choline Dehydrogenase and Sperm Function: Effects of Betaine [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the effects of betaine on sperm function in men with two minor alleles for choline dehydrogenase rs12676; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaine (betaine (trimethylglycine))

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Men Carrying 2 Minor Alleles for Choline Dehydrogenase rs12676, Male Infertility | Phase 1 | Status: COMPLETED